SC-70935

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSC-70935
Drug Alias NameLeridistimSC-70935
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin 3 receptor agonistsColony stimulating factor 3 receptor agonists
TargetsInterleukin 3 receptorColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia Corporation
Active IndicationsN/A
Inactive IndicationsNeutropenia

Other Information

ATC CodeN/A
Related LinksKEGG